Exobiosphere

📍 Esch-sur-Alzette, Luxembourg🗓 Founded 2024👥 21 employees💰 Last funded Apr 2025
Biotechnology Research🌐 exobiosphere.com
Website LinkedIn
The worlds first space focused pre-clinical contract research organization. Our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth. We’re building the world’s first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems. The goal is simple: make space a routine, essential part of the biomedical R&D pipeline so we can bring better and faster treatments to patients.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Luxembourg
1
Frequently asked questions
Who invested in Exobiosphere?
Exobiosphere has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Exobiosphere last raise funding?
The most recent investment in Exobiosphere recorded on gritt.io was in April 2025.
When was Exobiosphere founded?
Exobiosphere was founded in 2024.
What industry is Exobiosphere in?
Exobiosphere operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Exobiosphere based?
Exobiosphere is headquartered in Esch-sur-Alzette, Luxembourg.